http://120.24.161.253:5617/index.php?action=history&feed=atom&title=%E8%A1%80%E6%B6%B2%E7%97%85-%E4%B8%B4%E5%BA%8A%E8%A1%A8%E7%8E%B0-%E8%A1%80%E5%B0%8F%E6%9D%BF%E6%8A%97%E4%BD%93%E9%98%B3%E6%80%A7 2026-05-02T14:42:48Z 本wiki的该页面的版本历史 MediaWiki 1.30.0 http://120.24.161.253:5617/index.php?title=%E8%A1%80%E6%B6%B2%E7%97%85-%E4%B8%B4%E5%BA%8A%E8%A1%A8%E7%8E%B0-%E8%A1%80%E5%B0%8F%E6%9D%BF%E6%8A%97%E4%BD%93%E9%98%B3%E6%80%A7&diff=1669324&oldid=prev 2024-07-06T14:00:00Z

<p>修改1</p> <table class="diff diff-contentalign-left" data-mw="interface"> <tr style="vertical-align: top;" lang="zh-CN"> <td colspan="1" style="background-color: white; color:black; text-align: center;">←上一版本</td> <td colspan="1" style="background-color: white; color:black; text-align: center;">2024年7月6日 (六) 14:00的版本</td> </tr><tr><td colspan="2" style="text-align: center;" lang="zh-CN"><div class="mw-diff-empty">（没有差异）</div> </td></tr></table>

Admin http://120.24.161.253:5617/index.php?title=%E8%A1%80%E6%B6%B2%E7%97%85-%E4%B8%B4%E5%BA%8A%E8%A1%A8%E7%8E%B0-%E8%A1%80%E5%B0%8F%E6%9D%BF%E6%8A%97%E4%BD%93%E9%98%B3%E6%80%A7&diff=1669325&oldid=prev 2024-07-06T12:41:45Z

<p>导入1个版本</p> <table class="diff diff-contentalign-left" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr style="vertical-align: top;" lang="zh-CN"> <td colspan="2" style="background-color: white; color:black; text-align: center;">←上一版本</td> <td colspan="2" style="background-color: white; color:black; text-align: center;">2024年7月6日 (六) 12:41的版本</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l7" >第7行：</td> <td colspan="2" class="diff-lineno">第7行：</td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>==来源==</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>==来源==</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===血小板抗体对血小板输注效果的评价（中华医学会文献）===</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===血小板抗体对血小板输注效果的评价（中华医学会文献）===</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>结果 51例[[血液病]]患者检出[[血小板抗体阳性]]26例,占50.98%,1h和24h抗体阳性组(CCI值)明显低于抗体阴性组(P<del class="diffchange diffchange-inline">&lt;</del>0.01).</div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>结果 51例[[血液病]]患者检出[[血小板抗体阳性]]26例,占50.98%,1h和24h抗体阳性组(CCI值)明显低于抗体阴性组(P<ins class="diffchange diffchange-inline">&amp;amp;lt;</ins>0.01).</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===655例血液病患者血小板抗体筛查结果分析（中华医学会文献）===</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===655例血液病患者血小板抗体筛查结果分析（中华医学会文献）===</div></td></tr> <tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l13" >第13行：</td> <td colspan="2" class="diff-lineno">第13行：</td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===血小板抗体检测对肿瘤患者血小板输注疗效的影响（中华医学会文献）===</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===血小板抗体检测对肿瘤患者血小板输注疗效的影响（中华医学会文献）===</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>计学意义(P<del class="diffchange diffchange-inline">&lt;</del>0.05);[[血液病]]患者[[血小板抗体阳性]]检出率高于实体肿瘤,差异有统计学意义(P<del class="diffchange diffchange-inline">&lt;</del>0.05);既往有输血病史220例患者中,随输血次数的增多[[血小板抗体阳性]]率越高;配型相合输注血小板后1h CCI和24h CCI及输血疗效均显著高于随机输注患者(均</div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>计学意义(P<ins class="diffchange diffchange-inline">&amp;amp;lt;</ins>0.05);[[血液病]]患者[[血小板抗体阳性]]检出率高于实体肿瘤,差异有统计学意义(P<ins class="diffchange diffchange-inline">&amp;amp;lt;</ins>0.05);既往有输血病史220例患者中,随输血次数的增多[[血小板抗体阳性]]率越高;配型相合输注血小板后1h CCI和24h CCI及输血疗效均显著高于随机输注患者(均</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===血液病反复输血者血小板抗体对血小板输注效果的影响（中华医学会文献）===</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===血液病反复输血者血小板抗体对血小板输注效果的影响（中华医学会文献）===</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>结论 研究显示,[[血液病]]反复输血者[[血小板抗体阳性]],易对血小板输注效果产生影响,值得研究.</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>结论 研究显示,[[血液病]]反复输血者[[血小板抗体阳性]],易对血小板输注效果产生影响,值得研究.</div></td></tr> </table>

KGadmin http://120.24.161.253:5617/index.php?title=%E8%A1%80%E6%B6%B2%E7%97%85-%E4%B8%B4%E5%BA%8A%E8%A1%A8%E7%8E%B0-%E8%A1%80%E5%B0%8F%E6%9D%BF%E6%8A%97%E4%BD%93%E9%98%B3%E6%80%A7&diff=270576&oldid=prev 2021-10-21T08:01:54Z

<p>导入1个版本</p> <table class="diff diff-contentalign-left" data-mw="interface"> <tr style="vertical-align: top;" lang="zh-CN"> <td colspan="1" style="background-color: white; color:black; text-align: center;">←上一版本</td> <td colspan="1" style="background-color: white; color:black; text-align: center;">2021年10月21日 (四) 08:01的版本</td> </tr><tr><td colspan="2" style="text-align: center;" lang="zh-CN"><div class="mw-diff-empty">（没有差异）</div> </td></tr></table>

Admin http://120.24.161.253:5617/index.php?title=%E8%A1%80%E6%B6%B2%E7%97%85-%E4%B8%B4%E5%BA%8A%E8%A1%A8%E7%8E%B0-%E8%A1%80%E5%B0%8F%E6%9D%BF%E6%8A%97%E4%BD%93%E9%98%B3%E6%80%A7&diff=270568&oldid=prev 2021-10-19T13:56:59Z

<p>修改1</p> <p><b>新页面</b></p><div>主实体：[[血液病]]，关系：[[临床表现]] ，尾实体：[[血小板抗体阳性]]<br /> <br /> 实体ID:''1156358''<br /> ==关系介绍==<br /> 待补充<br /> <br /> ==来源==<br /> ===血小板抗体对血小板输注效果的评价（中华医学会文献）===<br /> 结果 51例[[血液病]]患者检出[[血小板抗体阳性]]26例,占50.98%,1h和24h抗体阳性组(CCI值)明显低于抗体阴性组(P&lt;0.01).<br /> <br /> ===655例血液病患者血小板抗体筛查结果分析（中华医学会文献）===<br /> 结果 655例[[血液病]]患者[[血小板抗体阳性]]有44例,占6.72％.<br /> <br /> ===血小板抗体检测对肿瘤患者血小板输注疗效的影响（中华医学会文献）===<br /> 计学意义(P&lt;0.05);[[血液病]]患者[[血小板抗体阳性]]检出率高于实体肿瘤,差异有统计学意义(P&lt;0.05);既往有输血病史220例患者中,随输血次数的增多[[血小板抗体阳性]]率越高;配型相合输注血小板后1h CCI和24h CCI及输血疗效均显著高于随机输注患者(均<br /> <br /> ===血液病反复输血者血小板抗体对血小板输注效果的影响（中华医学会文献）===<br /> 结论 研究显示,[[血液病]]反复输血者[[血小板抗体阳性]],易对血小板输注效果产生影响,值得研究.</div>

Admin